Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Proton Radiotherapy + Chemoimmunotherapy in Locally Advanced ESCC
NCT07034118Phase 1Not yet recruiting
- Sponsor
- The First Affiliated Hospital of USTC
- Start
- Aug 2025
- Primary completion
- Aug 2027
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial in Esophageal Squamous Cell Carcinoma (ESCC), sponsored by The First Affiliated Hospital of USTC. Primary endpoint: Toxicity at 1 year. Planned start Aug 2025; status: not yet recruiting.
02
Conditions
Esophageal Squamous Cell Carcinoma (ESCC)
Beyond the preview
Go deeper on NCT07034118.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07034118.